NEPHROS, INC. (NEPH) Return on equity 2017–2025
NEPHROS, INC. (NEPH) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
11.7%FY2025 · since FY2017: -41.5% → 11.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 11.7% | +10.8 pp |
| FY2024 | 0.9% | +19.7 pp |
| FY2023 | -18.8% | +108.2 pp |
| FY2022 | -127.1% | -94.0 pp |
| FY2021 | -33.1% | +3.1 pp |
| FY2020 | -36.1% | +31.9 pp |
| FY2019 | -68.0% | +21.6 pp |
| FY2018 | -89.6% | -48.1 pp |
| FY2017 | -41.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice